Influenza, Human/complications , Mediastinal Emphysema/diagnosis , Adult , Cough/etiology , Critical Illness/therapy , Fever/etiology , Humans , Influenza A Virus, H1N1 Subtype/drug effects , Influenza A Virus, H1N1 Subtype/pathogenicity , Male , Mediastinal Emphysema/etiology , Radiography/methods , Rupture, Spontaneous/diagnosis , Rupture, Spontaneous/etiology , Tomography, X-Ray Computed/methods
In a multicenter cohort study including 22 oseltamivir-treated patients with influenza A(H1N1)pdm09 acute respiratory distress syndrome, prevalence of the H275Y substitution in the neuraminidase, responsible for highly reduced sensitivity to oseltamivir, was 23%. Patients infected with the H275Y mutant virus had higher day 28 mortality than others (80% vs 12%; P = .011).
Influenza A Virus, H1N1 Subtype , Influenza, Human , Pneumonia , Respiratory Distress Syndrome , Antiviral Agents/pharmacology , Antiviral Agents/therapeutic use , Cohort Studies , Drug Resistance, Viral , Humans , Influenza A Virus, H1N1 Subtype/genetics , Influenza, Human/drug therapy , Neuraminidase/genetics , Oseltamivir/therapeutic use , Pneumonia/drug therapy , Respiratory Distress Syndrome/drug therapy
Acetaminophen/analysis , Gastric Absorption , Influenza, Human/blood , Acetaminophen/blood , Acetaminophen/therapeutic use , Antiviral Agents/therapeutic use , Humans , Influenza, Human/complications , Influenza, Human/physiopathology , Intensive Care Units/organization & administration , Intensive Care Units/statistics & numerical data , Pilot Projects
Embolism, Fat/complications , Infusions, Intraosseous/adverse effects , Abdominal Pain/etiology , Aged , Consciousness Disorders/diagnosis , Consciousness Disorders/etiology , Embolism, Fat/diagnostic imaging , Fever/etiology , Fever/physiopathology , Humans , Infusions, Intraosseous/methods , Magnetic Resonance Imaging/methods , Male
BACKGROUND: Pleural effusion is common during invasive mechanical ventilation, but its role during weaning is unclear. We aimed at assessing the prevalence and risk factors for pleural effusion at initiation of weaning. We also assessed its impact on weaning outcomes and its evolution in patients with difficult weaning. METHODS: We performed a prospective multicenter study in five intensive care units in France. Two hundred and forty-nine patients were explored using ultrasonography. Presence of moderate-to-large pleural effusion (defined as a maximal interpleural distance ≥ 15 mm) was assessed at weaning start and during difficult weaning. RESULTS: Seventy-three (29%) patients failed weaning, including 46 (18%) who failed the first spontaneous breathing trial (SBT) and 39 (16%) who failed extubation. Moderate-to-large pleural effusion was detected in 81 (33%) patients at weaning start. Moderate-to-large pleural effusion was associated with more failures of the first SBT [27 (33%) vs. 19 (11%), p < 0.001], more weaning failures [37 (47%) vs. 36 (22%), p < 0.001], less ventilator-free days at day 28 [21 (5-24) vs. 23 (16-26), p = 0.01], and a higher mortality at day 28 [14 (17%) vs. 14 (8%), p = 0.04]. The association of pleural effusion with weaning failure persisted in multivariable analysis and sensitivity analyses. Short-term (48 h) fluid balance change was not associated with the evolution of interpleural distance in patients with difficult weaning. CONCLUSIONS: In this multicenter observational study, pleural effusion was frequent during the weaning process and was associated with worse weaning outcomes.
Artifacts , Echocardiography, Transesophageal , Pulmonary Artery/diagnostic imaging , Pulmonary Embolism/diagnostic imaging , Echocardiography, Three-Dimensional , Humans , Legionnaires' Disease/complications , Male , Middle Aged , Pulmonary Embolism/complications , Respiratory Distress Syndrome/complications
Acute Kidney Injury/blood , Intensive Care Units/statistics & numerical data , Renal Dialysis/statistics & numerical data , Time Factors , beta-Lactams/analysis , beta-Lactams/toxicity , Acute Kidney Injury/epidemiology , Humans , Intensive Care Units/organization & administration , Prevalence , Sepsis/drug therapy , beta-Lactams/therapeutic use